申请人:Evopoint Biosciences Co., Ltd.
公开号:EP4074709A1
公开(公告)日:2022-10-19
Provided is a monocyclic β-lactam compound as shown in general formula (I), or an ester, a stereoisomer or a pharmaceutically acceptable salt thereof. Also provided are a pharmaceutical composition containing the monocyclic β-lactam compound as shown in general formula (I), or an ester, a stereoisomer or a pharmaceutically acceptable salt thereof, and the use thereof in the preparation of a drug for treating bacterial infections.
本发明提供了通式(I)所示的单环β-内酰胺化合物,或其酯、立体异构体或药学上可接受的盐。还提供了一种含有通式(I)所示单环β-内酰胺化合物或其酯、立体异构体或药学上可接受的盐的药物组合物,以及其在制备治疗细菌感染药物中的用途。